KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Return on Equity (2021 - 2025)

Ginkgo Bioworks Holdings' Return on Equity history spans 5 years, with the latest figure at 0.59% for Q4 2025.

  • For Q4 2025, Return on Equity rose 14.0% year-over-year to 0.59%; the TTM value through Dec 2025 reached 0.59%, up 14.0%, while the annual FY2025 figure was 0.51%, 9.0% up from the prior year.
  • Return on Equity reached 0.59% in Q4 2025 per DNA's latest filing, down from 0.58% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.28% in Q3 2021 to a low of 2.35% in Q3 2022.
  • Average Return on Equity over 5 years is 0.91%, with a median of 0.77% recorded in 2023.
  • Peak YoY movement for Return on Equity: crashed -207bps in 2022, then soared 173bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 1.15% in 2021, then decreased by -15bps to 1.32% in 2022, then surged by 43bps to 0.76% in 2023, then increased by 5bps to 0.72% in 2024, then increased by 19bps to 0.59% in 2025.
  • Per Business Quant, the three most recent readings for DNA's Return on Equity are 0.59% (Q4 2025), 0.58% (Q3 2025), and 0.5% (Q2 2025).